CZT专用心脏SPECT低剂量动态心肌灌注显像测量的心肌血流储备在INOCA患者中的预后价值
本研究回顾性纳入303例有冠状动脉造影资料的INOCA与阻塞性冠心病患者,用CZT专用心脏SPECT低剂量动态心肌灌注显像测量心肌血流储备(MFR)并电话随访,中位随访16个月。结果显示INOCA与阻塞性冠心病两组MACE发生率相似,但MFR降低者MACE发生率更高,INOCA与阻塞性冠心病亚组内均如此。
要点
- INOCA与阻塞性冠心病两组MACE发生率相似(log-rank P=0.2645)。
- MFR降低者MACE发生率高于MFR正常者(log-rank P=0.0019)。
- INOCA组37例MFR降低者MACE发生率高于MFR正常者(log-rank P=0.0186)。
核心结论
- 低剂量动态心肌灌注显像CZT SPECT测量的MFR为INOCA患者提供增量预后价值。
- MFR降低的患者MACE风险增加、症状负担加重、生活质量受损。
- MFR降低的INOCA患者MACE发生率高于MFR正常的阻塞性冠心病患者。
研究设计与样本
- 回顾性分析连续筛选在动态心肌灌注显像前后三个月内有冠状动脉造影资料的INOCA与阻塞性冠心病患者。
- 最终分析纳入303例(男159例、女144例),排除24例失访者,平均年龄61.94±8.59岁。
- 其中阻塞性冠心病203例(67.0%)、INOCA 100例(33.0%),中位随访16个月(14-21个月)。
- INOCA定义为有心肌缺血体征和/或症状但心外膜狭窄<50%,阻塞性冠心病定义为心外膜冠状动脉或其主要分支狭窄≥50%。
- 采用Kaplan-Meier生存曲线、Log-rank检验和单因素COX回归分析评估预后及相关预测因素,P<0.05为有统计学意义。
主要发现
- Kaplan-Meier曲线显示INOCA组与阻塞性冠心病组MACE发生率相似(log-rank P=0.2645)。
- MFR降低者MACE发生率高于MFR正常者(log-rank P=0.0019)。
- 阻塞性冠心病亚组中105例MFR降低者MACE发生率高于MFR正常者(log-rank P=0.0226)。
- INOCA亚组中37例MFR降低者MACE发生率高于MFR正常者(log-rank P=0.0186)。
- 单因素COX回归显示MFR每增加1单位,INOCA患者MACE风险降低66.1%、阻塞性冠心病患者降低64.2%;左室标化心肌血流量每增加1 mL·g-1·min-1,INOCA患者MACE风险降低72.4%、阻塞性冠心病患者降低63.6%。
临床怎么用
- 原文结论认为低剂量动态心肌灌注显像CZT SPECT测量的MFR对INOCA患者具有增量预后价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical use of dynamic myocardial perfusion imaging (D-MPI) of cadmium-zinc-telluride (CZT) cardiac-dedicated SPECT is growing, showing a higher application value than conventional SPECT. The prognostic value of ischemia in patients with non-obstructive coronary arteries (INOCA) remains an important challenge for investigation. The primary objective of this study was to investigate the prognostic value of myocardial flow reserve (MFR) measured with low-dose D-MPI of CZT cardiac-dedicated SPECT in the assessment of patients with INOCA. METHODS: Consecutive screening of patients with INOCA and obstructive coronary artery disease (OCAD) who had coronary angiography (CAG) data was performed within three months before or after D-MPI imaging. The patients who met the inclusion criteria were retrospectively analyzed and follow-up by telephone was performed. The enrolled patients were then divided into the INOCA and OCAD groups. INOCA was defined as signs and/or symptoms of myocardial ischemia but with < 50% epicardial stenosis. OCAD was defined as obstructive stenosis (≥ 50% stenosis) of epicardial coronary arteries or their major branches on the CAG. Medical treatments, Seattle Angina Questionnaire (SAQ) scores, and major adverse cardiac events (MACEs) were studied. The Kaplan-Meier survival curve, Log-rank test, and univariable COX regression analysis were used to evaluate the prognosis of patients and associated predictors, with P < 0.05 being considered statistically significant. RESULTS: A total of 303 patients (159 males and 144 females) were enrolled for the final analysis after excluding 24 patients who were lost to follow-up. The mean age of the included cases was 61.94 ± 8.59 years, of which 203 (67.0%) cases were OCAD and 100 (33.0%) cases were INOCA, respectively. The median follow-up was 16 months (14-21 months). Kaplan-Meier survival curves showed that the incidence of MACE was similar in the INOCA and OCAD groups (log-rank P = 0.2645), while those with reduced MFR showed a higher incidence of MACE than those with normal MFR (log-rank P = 0.0019). The subgroup analysis in the OCAD group revealed that 105 patients with reduced MFR had a higher incidence of MACE than those with normal MFR (log-rank P = 0.0226). The subgroup analysis in the INOCA group showed that 37 patients with reduced MFR had a higher incidence of MACE than those with normal MFR in the INOCA group (log-rank P = 0.0186). Univariable Cox regression analysis showed for every 1 unit increase in MFR, the risk of MACE for INOCA was reduced by 66.1% and that for OCAD by 64.2%. For each 1 mL·g-1·min-1 increase in LV-sMBF, the risk of MACE was reduced by 72.4% in INOCA patients and 63.6% in OCAD patients. CONCLUSIONS: MFR measured with low-dose D-MPI CZT SPECT provides incremental prognostic value in patients with INOCA. Patients with reduced MFR show an increased risk of MACE, increased symptom burdens, and impaired quality of life. INOCA patients with reduced MFR experienced higher rate of MACE than OCAD patients with normal MFR.
引用
- Li L, Pang Z, Wang J, et al. Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA. J Nucl Cardiol. 2023. PMID: 37434083. doi:10.1007/s12350-023-03332-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。